首页> 美国卫生研究院文献>Environmental Health Perspectives >Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal waste reduction and future directions.
【2h】

Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal waste reduction and future directions.

机译:药物从摇篮到摇篮的管理以最大程度地减少其对环境的影响同时促进人类健康。二。药物处理减少废物以及未来的方向。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since the 1980s, the occurrence of pharmaceuticals and personal care products (PPCPs) as trace environmental pollutants, originating primarily from consumer use and actions rather than manufacturer effluents, continues to become more firmly established. The growing, worldwide importance of freshwater resources underscores the need for ensuring that any aggregate or cumulative impacts on (or from) water supplies are minimized. Despite a paucity of effects data from long-term, simultaneous exposure at low doses to multiple xenobiotics (particularly non-target-organism exposure to PPCPs), a wide range of proactive actions could be implemented for reducing or minimizing the introduction of PPCPs to the environment. Most of these actions fall under what could be envisioned as a holistic stewardship program--overseen by the health care industry and consumers alike. Significantly, such a stewardship program would benefit not just the environment--additional, collateral benefits could automatically accrue, including the lessening of medication expense for the consumer and improving patient health and consumer safety. In this article (the second of two parts describing the "green pharmacy") I focus on those actions and activities tied more closely to the end user (e.g., the patient) and issues associated with drug disposal/recycling that could prove useful in minimizing the environmental disposition of PPCPs. I also outline some recommendations and suggestions for further research and pose some considerations regarding the future. In this mini-monograph I attempt to capture cohesively for the first time the wide spectrum of actions available for minimizing the release of PPCPs to the environment. A major objective is to generate an active dialog or debate across the many disciplines that must become actively involved to design and implement a successful approach to life-cycle stewardship of PPCPs.
机译:自1980年代以来,作为主要环境污染物的药物和个人护理产品(PPCP)的发生主要源于消费者的使用和行动,而不是制造商的废水,这种情况仍在不断地确立。淡水资源在全球范围内的重要性日益凸显,需要确保对水供应(或来自水供应)的任何总体或累积影响最小化。尽管长期低剂量同时暴露于多种异源生物(尤其是非靶标生物接触PPCP)的影响数据很少,但仍可以采取广泛的积极行动来减少或尽量减少将PPCP引入动物体内。环境。这些行动大多数都属于可以预见的整体管理计划-由医疗保健行业和消费者共同监督。值得注意的是,这样的管理计划不仅会有益于环境,还会自动产生额外的附带利益,包括减少消费者的药品费用并改善患者的健康和消费者的安全性。在本文(描述“绿色药房”的第二部分中的第二部分)中,我着重讨论与最终用户(例如患者)联系更紧密的那些行为和活动,以及与药物处置/回收相关的问题,这些问题可能有助于最大程度地减少PPCP的环境处置。我还概述了一些进一步研究的建议和建议,并对未来进行了一些考虑。在这本微型专题文章中,我尝试首次凝聚力地捕获可用于最大限度地减少PPCP向环境释放的各种行动。一个主要目标是在必须积极参与设计和实施成功的PPCP生命周期管理方法的众多学科之间进行活跃的对话或辩论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号